| The life cycle of health technologies. Challenges and ways forward I Gutiérrez-Ibarluzea, M Chiumente, HP Dauben Frontiers in Pharmacology 8, 249434, 2017 | 35 | 2017 |
| Analysis of survival curves: statistical methods accounting for the presence of long-term survivors V Damuzzo, L Agnoletto, L Leonardi, M Chiumente, D Mengato, ... Frontiers in oncology 9, 453, 2019 | 34 | 2019 |
| Comorbidity, polytherapy, and drug interactions in a neurological context: an example of a multidisciplinary approach to promote the rational use of drugs G Busa, A Burlina, V Damuzzo, M Chiumente, AC Palozzo Journal of pharmacy practice 31 (1), 58-65, 2018 | 26 | 2018 |
| Efficacy of immune checkpoint inhibitors in patients with mismatch repair-deficient or microsatellite instability-high metastatic colorectal cancer: analysis of three phase-II … L Cancanelli, M Rivano, L Di Spazio, M Chiumente, D Mengato, ... Cureus 13 (11), 2021 | 17 | 2021 |
| A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia A Messori, M Rivano, D Mengato, L Cancanelli, L Di Spazio, ... Leukemia & Lymphoma 63 (5), 1261-1264, 2022 | 16 | 2022 |
| The degree of programmed death-ligand 1 (PD-L1) positivity as a determinant of outcomes in metastatic triple-negative breast cancer treated with first-line immune checkpoint … L Di Spazio, M Rivano, L Cancanelli, M Chiumente, D Mengato, ... Cureus 14 (1), 2022 | 16 | 2022 |
| A model-independent method to determine restricted mean survival time in the analysis of survival curves A Messori, V Damuzzo, L Agnoletto, L Leonardi, M Chiumente, ... SN Comprehensive Clinical Medicine 2 (1), 66-68, 2020 | 16 | 2020 |
| Capacity building in agencies for efficient and effective health technology assessment D Mueller, I Gutiérrez-Ibarluzea, T Schuller, M Chiumente, J Ahn, ... International Journal of Technology Assessment in Health Care 32 (4), 292-299, 2016 | 15 | 2016 |
| Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data A Ossato, V Damuzzo, P Baldo, D Mengato, M Chiumente, A Messori Cancer Medicine 12 (3), 2155-2165, 2023 | 11 | 2023 |
| Medical therapy, radiofrequency ablation, or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through the shiny method S Trippoli, L Di Spazio, M Chiumente, A Messori Cureus 14 (2), 2022 | 9 | 2022 |
| Tisagenlecleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median M Chiumente, D Mengato, A Messori Acta Haematologica 143 (6), 598-599, 2020 | 9 | 2020 |
| Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy PAC Damuzzo V, Russi A, Chiumente M, Masini C, Rebesco B, Gregis F, Nozza S ... J Oncol Pharm Pract., 2018 | 9* | 2018 |
| Burden of stroke in Italy: An economic model highlights savings arising from reduced disability following thrombolysis M Chiumente, MM Gianino, D Minniti, TJ Mattei, B Spass, KM Kamal, ... International Journal of Stroke 10 (6), 849-855, 2015 | 9 | 2015 |
| Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis MF Cabiddu, A Russi, L Appolloni, D Mengato, M Chiumente European Journal of Hospital Pharmacy 29 (3), 134-138, 2022 | 8 | 2022 |
| Application of the Ipdfromkm-shiny method to compare the efficacy of novel treatments aimed at the same disease condition: a report of 14 analyses A Messori, V Damuzzo, M Rivano, L Cancanelli, L Di Spazio, A Ossato, ... Cancers 15 (6), 1633, 2023 | 7 | 2023 |
| Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe D Mueller, I Gutierrez-Ibarluzea, M Chiumente, W Oortwijn International Journal of Technology Assessment in Health Care 37 (1), e29, 2021 | 7 | 2021 |
| Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women M Chiumente, M De Rosa, A Messori, EM Proli ClinicoEconomics and Outcomes Research 9, 525—535, 2017 | 7 | 2017 |
| Il costo della distribuzione diretta dei farmaci in dieci Aziende Sanitarie piemontesi FC Claudio Jommi, Alessandra Bianco, Marco Chiumente, Giulia Valinotti Giornale Italiano di Farmacia Clinica 29 (3), 152-169, 2015 | 7 | 2015 |
| Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study A Russi, V Damuzzo, M Chiumente, J Pigozzo, M Cesca, ... Journal of Chemotherapy 29 (4), 245-251, 2017 | 6 | 2017 |
| Survival in patients with relapsed-refractory multiple myeloma: indirect comparison of six new treatments L Cancanelli, M Rivano, L Di Spazio, M Chiumente, D Mengato, ... Preprints, 2022 | 5 | 2022 |
Andrea MessoriHTA Unit, ESTAR Toscana; Tuscany Region Health Service; University of FirenzeGeverifieerd e-mailadres voor estar.toscana.it
